OKYO Pharma Ltd. Form 6-K Summary
Filing date: September 7, 2022
Reporting period: The filing does not report a financial period; it covers a corporate announcement.
Business Context
OKYO Pharma Ltd, a foreign private issuer filing annual reports on Form 20-F, furnished a United Kingdom news service announcement regarding the results of its Annual General Meeting. The announcement was included as Exhibit 99.1.
Financial and Operating Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, liquidity, operating metrics, or other financial data.
Material Changes
The filing text does not identify material changes versus a prior comparable period. It only reports the results of the Annual General Meeting; the specific voting outcomes are not included in the provided text.
Guidance, Outlook, Risks, and Unusual Items
No guidance, outlook, management commentary, risks, contingencies, or unusual financial items are described in the filing text provided.
Investor Verification Items
- Review Exhibit 99.1 for the detailed Annual General Meeting results and voting outcomes.
- Verify whether any resolutions were approved, rejected, or amended.
- Consult the company’s related annual or interim filings for financial condition, liquidity, and operating results, which are not provided in this Form 6-K text.